Results 11 to 20 of about 1,094 (192)

Stereocontrolled semi-syntheses of deguelin and tephrosin [PDF]

open access: yesOrganic & Biomolecular Chemistry, 2017
We describe stereocontrolled semi-syntheses of deguelin and tephrosin, anti-cancer rotenoids isolated from Tephrosia vogelii .
Russell, David A   +4 more
openaire   +6 more sources

Deguelin attenuates reperfusion injury and improves outcome after orthotopic lung transplantation in the rat. [PDF]

open access: yesPLoS ONE, 2012
The main goal of adequate organ preservation is to avoid further cellular metabolism during the phase of ischemia. However, modern preservation solutions do rarely achieve this target.
Patrick Paulus   +8 more
doaj   +3 more sources

BAD, a Proapoptotic Protein, Escapes ERK/RSK Phosphorylation in Deguelin and siRNA-Treated HeLa Cells. [PDF]

open access: yesPLoS ONE, 2016
This study has been undertaken to explore the therapeutic effects of deguelin and specific siRNAs in HeLa cells. The data provided clearly show the silencing of ERK 1/2 with siRNAs and inhibition of ERK1/2 with deguelin treatment in HeLa cells ...
Samra Hafeez   +15 more
doaj   +2 more sources

Deguelin induces both apoptosis and autophagy in cultured head and neck squamous cell carcinoma cells. [PDF]

open access: yesPLoS ONE, 2013
Head and neck squamous cell carcinoma (HNSCC) represents more than 5% of all cancers diagnosed annually in United States and around the world. Despite advances in the management of patients with this disease, the survival has not been significantly ...
Yan-li Yang   +6 more
doaj   +2 more sources

Antiangiogenic Effect of Deguelin on Choroidal Neovascularization

open access: yesThe Journal of Pharmacology and Experimental Therapeutics, 2008
Age-related macular degeneration is the leading cause of blindness in the elderly. Choroidal neovascularization (CNV) leads to severe vision loss in patients of age-related macular degeneration. Previously, we have demonstrated that deguelin, isolated from plants in the Mundulea sericea family, is a chemopreventive agent.
Jeong Hun, Kim   +6 more
openaire   +3 more sources

Akt inhibitor deguelin aggravates inflammation and fibrosis in myocarditis [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2019
Objective(s): Myocarditis is characterized by inflammatory cell infiltration in myocardial stroma. Attenuation of tumor necrosis factor (TNF)-α and interleukin (IL)-1β is a reliable mark for improving the prognosis.
Shanshan Li   +10 more
doaj   +3 more sources

Efficacy of Deguelin and Silibinin on Benzo(a)pyrene-Induced Lung Tumorigenesis in A/J Mice [PDF]

open access: yesNeoplasia: An International Journal for Oncology Research, 2005
We evaluated deguelin and silibinin in A/J mice treated with the tobacco-specific carcinogen benzo(a)pyrene (BP) for their ability to inhibit pulmonary adenoma formation and growth. Animals were treated with either deguelin (5.0 or 10.0 mg/kg body weight,
Ying Yan   +4 more
doaj   +2 more sources

Deguelin induces apoptosis in colorectal cancer cells by activating the p38 MAPK pathway

open access: yesCancer Management and Research, 2018
Liubo Chen,1,2,* Kai Jiang,1,2,* Haiyan Chen,1,3,* Yang Tang,1,2 Xinyi Zhou,1,2 Yinuo Tan,1,4 Ying Yuan,1,4 Qian Xiao,1,2 Kefeng Ding1,2 1Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key ...
Chen L   +8 more
doaj   +1 more source

Deguelin targets multiple oncogenic signaling pathways to combat human malignancies

open access: yesPharmacological Research, 2021
Cancer is an anomalous growth and differentiation of cells known to be governed by oncogenic factors. Plant-based natural metabolites have been well recognized to possess chemopreventive properties. Deguelin, a natural rotenoid, is among the class of bioactive phytoconstituents from a diverse range of plants with potential antineoplastic effects in ...
Hardeep Singh Tuli   +11 more
openaire   +3 more sources

Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.

open access: yesPLoS ONE, 2013
BackgroundTreatment of breast cancer patients with antiestrogens and aromatase inhibitor(s) or Herceptin have shown significant success in steroid receptor positive or Her-2+ breast cancers respectively.
Rajeshwari Mehta   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy